Article Versions Notes

Menzella F, Marchi M, Caminati M, Romagnoli M, Micheletto C, Bonato M, Idotta G, Nizzetto M, D’Alba G, Cavenaghi M, et al. Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma. Journal of Clinical Medicine. 2025; 14(1):191. https://doi.org/10.3390/jcm14010191

Menzella, Francesco, Mariarita Marchi, Marco Caminati, Micaela Romagnoli, Claudio Micheletto, Matteo Bonato, Giuseppe Idotta, Manuele Nizzetto, Giuseppina D’Alba, Massimiliano Cavenaghi, and et al. 2025. "Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma" Journal of Clinical Medicine 14, no. 1: 191. https://doi.org/10.3390/jcm14010191

Menzella, F., Marchi, M., Caminati, M., Romagnoli, M., Micheletto, C., Bonato, M., Idotta, G., Nizzetto, M., D’Alba, G., Cavenaghi, M., Bortoli, M., Beghè, B., Pini, L., Benoni, R., Casoni, G., Muzzolon, R., Michieletto, L., Bosi, A., Mastrototaro, A., ... Senna, G. (2025). Long-Term Eosinophil Depletion: A Real-World Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma. Journal of Clinical Medicine, 14(1), 191. https://doi.org/10.3390/jcm14010191